AzTrials
AzTrials

Uterine AnteflexionFLEXIMIX3NCT07803627

Changes in the Angle of Uterine Flexion as the Bladder Fills

A study testing Ultrasonography, Pelvic in people with Uterine Anteflexion, run by University Hospital, Brest at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate how bladder filling affects the uterine flexion angle in adult nulliparous women with a uterine flexion angle <90° when the bladder is empty. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Uterine Anteflexion
What is being tested?
Ultrasonography, Pelvic
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
15 Sep 2026to 15 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult woman
  • Nulliparous
  • Registered with a social security scheme
  • Uterine flexion angle < 90°, empty bladder

Who cannot join

  • Pregnant woman
  • Woman wishing to become pregnant and currently trying to conceive
  • Primary amenorrhoea
  • Menopause
  • History of surgical termination of pregnancy
  • History of medical termination of pregnancy
Show all 11Show fewer
  • History of hysterectomy
  • History of conisation
  • Absence of the uterus
  • Symptoms of urinary tract infection (gross haematuria, burning on urination, frequent urination)
  • Under legal guardianship (curatorship, trusteeship)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Benoit CHIRON

    Le Relecq-Kerhuon, 29480

    Benoit CHIRON, MD, benoitchiron@yahoo.fr

Other trials in France

About this study

Official title: Prospective Study of the Changes in the Angle of Uterine Flexion as the Bladder Fills

The goal of this clinical trial is to evaluate how bladder filling affects the uterine flexion angle in adult nulliparous women with a uterine flexion angle <90° when the bladder is empty.

The main questions it aims to answer are:

How does the uterine flexion angle change as bladder volume increases? What bladder volume is needed to obtain a uterine flexion angle >90°?

Participants will:

Drink 600 mL of water following a standardized protocol. Undergo repeated suprapubic ultrasound measurements of bladder volume and uterine flexion angle.

Remain under observation until urination or for a maximum of 4 hours. No comparison group is included in this study.

Being tested
Ultrasonography, Pelvic
Keywords
Uterine anteflexion, Nulliparous women, Bladder filling, Ultrasound measurements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasonography, PelvicProcedure or surgery

    Repeated ultrasound measurements, alternating between volume and angle of flexion, immediately following a hydration protocol and then bladder emptying.

Study groups in NCT07803627
Study groupRoleWhat they receive
Ultrasonography pelvicOtherRepeated ultrasound measurements, alternating between volume and angle of flexion, immediately following a hydration protocol and then bladder emptying.
Receives: Procedure: Ultrasonography, Pelvic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Uterine Flexion Angle Measured at Different Bladder Volumes in Nulliparous Women With an Anteverted Uterus and Baseline Uterine Flexion Angle <90°

    The relationship between bladder volume and the angle of uterine flexion, as determined from repeated ultrasound measurements in the participants.

    Measured: 4 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2026
  2. Study start15 Sep 2026 (estimated)
  3. Primary completion15 Mar 2027 (estimated)
  4. Study completion15 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07803627
Sponsor's protocol ID
29BRC25.0436
Acronym
FLEXIMIX3
Status last verified
Sep 2026
First submitted
28 Aug 2026
Last updated
3 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasonography, Pelvic in people with Uterine Anteflexion, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Benoit CHIRON, MD (02 98 40 19 21 ext. +33, benoitchiron@yahoo.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Uterine Flexion Angle Measured at Different Bladder Volumes in Nulliparous Women With an Anteverted Uterus and Baseline Uterine Flexion Angle <90° (time frame: 4 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in